Published On: Wed, Oct 19th, 2016

Latest Analyst Reports On Integra LifeSciences Holdings Corporation


Recently stock market analysts have updated their consensus ratings on shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART).

Most recent broker ratings

10/04/2016 – Integra LifeSciences Holdings Corporation had its “outperform” rating reiterated by analysts at Oppenheimer. They now have a USD 93 price target on the stock.

09/26/2016 – Integra LifeSciences Holdings Corporation had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 95 price target on the stock.

09/23/2016 – Integra LifeSciences Holdings Corporation had its “buy” rating reiterated by analysts at Argus. They now have a USD 105 price target on the stock.

08/19/2016 – Integra LifeSciences Holdings Corporation had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 94 price target on the stock.

07/29/2016 – Integra LifeSciences Holdings Corporation had its “equal weight” rating reiterated by analysts at Barclays. They now have a USD 84 price target on the stock.

07/13/2016 – Integra LifeSciences Holdings Corporation had its “overweight” rating reiterated by analysts at JP Morgan.

11/12/2015 – Citigroup began new coverage on Integra LifeSciences Holdings Corporation giving the company a “buy” rating. They now have a USD 75 price target on the stock.

09/21/2015 – Integra LifeSciences Holdings Corporation was upgraded to “buy” by analysts at Bank of America Merrill Lynch. They now have a USD 79 price target on the stock.

08/26/2015 – Integra LifeSciences Holdings Corporation had its “hold” rating reiterated by analysts at Lake Street. They now have a USD 55 price target on the stock.

07/29/2015 – Integra LifeSciences Holdings Corporation was upgraded to “outperform” by analysts at Raymond James.

05/05/2015 – Integra LifeSciences Holdings Corporation was upgraded to “buy” by analysts at Zacks. They now have a USD 73 price target on the stock.

05/04/2015 – Integra LifeSciences Holdings Corporation was upgraded to “outperform” by analysts at Wells Fargo.

05/04/2015 – Integra LifeSciences Holdings Corporation had its “sector perform” rating reiterated by analysts at RBC Capital. They now have a USD 66 price target on the stock.

02/27/2014 – Integra LifeSciences Holdings Corporation had its “” rating reiterated by analysts at SunTrust. They now have a USD 43 price target on the stock.

11/11/2013 – Integra LifeSciences Holdings Corporation was upgraded to “equal weight” by analysts at Morgan Stanley. They now have a USD 40 price target on the stock.

Integra LifeSciences Holdings Corporation has a 50 day moving average of 84.59 and a 200 day moving average of 78.31. The stock’s market capitalization is 3.05B, it has a 52-week low of 54.75 and a 52-week high of 88.86.

The share price of the company (NASDAQ:IART) was up +1.09%, with a high of 81.96 during the day and the volume of Integra LifeSciences Holdings Corporation shares traded was 290440.